Earn points on every order New products in stock Free 51-page beginner’s guide
← Back to Compound Library

OXYTOCIN

The “bonding hormone.” Released during touch, intimacy, and childbirth; it promotes trust, connection, and calm. Used (usually as a nasal spray) for social/mood support and intimacy.

Research referenceCommunity compiled

Molecular profile

The molecule itself: sequence, composition, mass, target, and registry identifiers.

Molecular formula
C₄₃H₆₆N₁₂O₁₂S₂
Average mass
1007.2 Da
CAS number
50-56-6
Registry
PubChem CID 439302
Receptor / pathway
OXTR
Formula, mass and identifiers from PubChem CID 439302.
Research & reference information

This profile compiles research and community-sourced reference information for educational purposes. Information may evolve as research and community knowledge develop. It is not individualized medical advice.

Overview

Oxytocin is a naturally occurring nine-amino-acid hypothalamic neuropeptide widely known as the human "bonding and trust hormone." What problem it targets: It targets chronic social anxiety, emotional blunting, elevated stress response, low relationship bonding, and female/male sexual dysfunction (anorgasmia).

What It Does

• Calms amygdala hyper-reactivity: Directly dampens fear and threat signaling in the brain's amygdala, reducing social anxiety and promoting feelings of safety and empathy.

• Enhances sexual arousal and orgasm: Promotes smooth muscle contractions in reproductive tracts and intensifies sexual satisfaction, intimacy, and climactic response.

• Lowers cortisol and sympathetic tone: Dampens the body's fight-or-flight autonomic response, lowering elevated heart rate and blood pressure under psychological stress.

• Realistic expectations: Typically administered via intranasal spray or low-dose subcutaneous injection 30 to 60 minutes prior to social situations or intimacy. Delivers rapid, transient mood elevation and relaxation.

Reconstitution

Vial sizeBAC water / SalineConcentrationNote
2 mg+ 1 mL2 mg/mL (~1000 IU/mL)~1 mg ≈ 500 IU. For nasal use, transfer to a metered spray.
10 mg+ 5 mL2 mg/mL (~1000 IU/mL)1 unit (SubQ) = 0.02 mg

Protocol

RouteFrequencyDoseNotes
IntranasalAs needed or 1–2×/day24–40 IU (~3 sprays/nostril at ~4 IU each)Most common route for social/mood effects. Onset ~30–45 min.
SubQAs needed5–10 IU (~50–100 mcg)Faster, stronger peripheral effect; lower CNS targeting than intranasal. Cycle: use as-needed, or 24 IU twice daily for 4–12 weeks in chronic-dosing protocols. Timing: ~30–45 min before the desired social/intimacy effect (intranasal). Note: short-acting; effects are situational, not cumulative. By sex: Bonding and intimacy in both sexes; in women, sensitivity can shift with estrogen across the cycle.

Handling & Stacking

Injection site
Intranasal spray (primary) or SubQ abdomen.
Storage
  • Freeze-dried: -4°F.
  • Reconstituted: 36–46°F; nasal bottle best used within ~2–4 weeks (this is the one compound here with real published stability data); keep it cold and dark.
  • Protect from light.
Side effects
Usually mild, nasal irritation, headache, mood shifts. Higher/frequent doses can blunt receptors or cause emotional flattening.
What to expect
  • Situational increase in warmth, trust, calm, and intimacy.
  • Effects are short-lived and context-dependent.
  • Supply math 2mg → 3 vials | 10mg → 1 vial (8-wk @ ~24 IU 2/day; far less if as needed)
Pairs well with
PT-141 (intimacy); Kisspeptin (libido/hormonal); Selank (anxiolytic)
Avoid
Pregnancy (uterotonic). Hyponatremia / excessive water intake (antidiuretic effect at high doses). Overuse (receptor blunting)

Safety & Patient Education

Contraindications
Pregnancy (uterotonic, can trigger contractions) Hyponatremia or conditions of water overload Hypersensitivity to oxytocin
Warnings
Antidiuretic (vasopressin-like) effect at high doses, water retention / hyponatremia risk Receptor blunting / emotional flattening with frequent high dosing Can intensify or distort emotional responses, situational Cardiovascular effects (BP/heart rate) at high doses
Drug interactions
Vasoconstrictors / some migraine drugs: additive cardiovascular effects Excess fluids: compounds hyponatremia risk
Labs
Sodium if using high/frequent doses Generally none for occasional intranasal use Out of range? Low sodium = too much / too frequent dosing → ease off.
Stop criteria
Headache, confusion, nausea (possible hyponatremia) Emotional flattening or worsened mood Any uterine cramping (if applicable)
Patient education
Short-acting and situational, not a daily mood drug for most Don’t over-dose; more can blunt the effect and flatten emotion Avoid in pregnancy Don’t combine high doses with excessive water intake
References
researchdosing · peptidedosages · PubMed · thepeptidereport · Oxytocin sex differences